Barclays »

Iovance Biotherapeutics shares owned by Barclays

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.8M 836k 8.13
2023-09-30 $3.4M 758k 4.55
2023-06-30 $3.7M 530k 7.04
2023-03-31 $2.5M 417k 6.11
2022-12-31 $4.0M 631k 6.39
2022-09-30 $3.7M 391k 9.58
2022-06-30 $479k 43k 11.04
2022-03-31 $1.2M 73k 16.66
2021-12-31 $114k 6.0k 19.06
2021-09-30 $761k 31k 24.63
2021-06-30 $2.3M 90k 26.03
2021-03-31 $2.2M 68k 31.68
2020-12-31 $3.1M 67k 46.40
2020-09-30 $1.9M 59k 32.91
2020-06-30 $5.3M 192k 27.45
2020-03-31 $3.6M 122k 29.94
2019-12-31 $5.9M 214k 27.68
2019-09-30 $1.9M 106k 18.20
2019-06-30 $1.8M 75k 24.52
2019-03-31 $533k 56k 9.52
2018-09-30 $539k 48k 11.26
2018-06-30 $167k 13k 12.80
2018-03-31 $291k 17k 16.88
2017-12-31 $286k 36k 7.99
2017-09-30 $25k 3.2k 7.73
2017-06-30 $0 40 0.00